Cipla unit gets a Voluntary Action Indicated status from the USFDA

The US drug regulator had conducted a routine current Good Manufacturing Practices (cGMP) inspection at the said facility between November 7 to November 13, 2024.

Leave a Reply

Your email address will not be published. Required fields are marked *